MIRAPEXIN 2.1 mg prolonged-release tablets

Company
Boehringer Ingelheim Limited
Active Ingredient
Strength
  • 2.1 mg
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed
Last Updated
25/09/2026
Licence number Strength ATC Code Dosage Form
EU/1/97/051/22 2.1 mg N04BC05 Prolonged-release tablet
EU/1/97/051/23 2.1 mg N04BC05 Prolonged-release tablet
EU/1/97/051/24 2.1 mg N04BC05 Prolonged-release tablet
Licence number
EU/1/97/051/22
Strength
2.1 mg
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/051/23
Strength
2.1 mg
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/051/24
Strength
2.1 mg
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9

Email
medinfo.ukie@boehringer-ingelheim.com